BioVie Inc. (BIVI) Stock Forecast
BIVI analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 2 analysts
- Price target
- $5.25 average of analyst targets
- Upside to target
- +337.9% from the latest close
- Next earnings
- November 9, 2026
- 52-week range
- $0.96 – $2.28
BIVI analyst ratings
2 analystsNumber of analysts at each rating.
BIVI price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
BIVI earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current fiscal year (FY2027) | −$0.63 | −$0.63 | −$0.63 | −$3.05 | +79.3% | 1 |
| Next fiscal year (FY2028) | −$0.57 | −$0.57 | −$0.57 | −$0.63 | +9.5% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
BIVI revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current fiscal year (FY2027) | $0 | $0 | $0 | 0.0% | 1 |
| Next fiscal year (FY2028) | $0 | $0 | $0 | 0.0% | 1 |
BIVI EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
BIVI EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current fiscal year (FY2027) | $0.00 | $0.00 | $0.00 | $0.00 | −$0.63 | — | 0 up · 0 down |
| Next fiscal year (FY2028) | $0.00 | $0.00 | $0.00 | $0.00 | −$0.57 | — | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
BIVI earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; BIVI beat in 5 of 10.
What analysts expect from BIVI
2 analysts cover BioVie; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $5.25, 337.9% above the latest close of $1.20. Analysts expect earnings of −$0.63 per share for FY2027, +79.3% from a year earlier. For FY2028 the average estimate is −$0.57 per share. BioVie beat the EPS estimate in 5 of the last 10 quarters.
Related: BIVI income statement, BIVI key metrics, BIVI chart. See the BIVI stock overview for the latest quote and news.
BIVI forecast FAQ
What is BioVie's price target?
The average analyst price target for BioVie is $5.25, 337.9% above the latest close of $1.20.
Is BioVie a buy, hold or sell?
Of 2 analysts covering BioVie, 2 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is BioVie's EPS forecast?
Analysts forecast −$0.63 per share for FY2027 (range −$0.63 to −$0.63); for FY2028 the estimate is −$0.57.
When does BioVie report earnings?
BioVie is expected to report results for the quarter ending September 30, 2026 on November 9, 2026 after the market closes.
Does BioVie usually beat earnings estimates?
BioVie reported EPS at or above the analyst estimate in 5 of the last 10 quarters.